Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q2 FY22 Earnings Conference Call Transcript Windlas Biotech Ltd - 543329 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Asset Management Company Ltd
Earnings Call for Q2FY22 of Windlas Biotech
Conference Call with Windlas Biotech Ltd. Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript. Windlas Biotech Ltd - 543329 - Announcement Under Regulation 32 - Statement Of Deviation
Statement of deviation(s) or variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Windlas Biotech Ltd - 543329 - Regulation 32(6)
Report of the Monitoring Agency under Reg 32 (6) Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation
Results Presentation for the Quarter and half year ended September 30, 2021 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2021